Pulmonx Corp (LUNG) › Cash & EquivalentsPulmonx Corp (LUNG) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2018-12-31: $4.12M2019-12-31: $14.77M2020-12-31: $231.56M2021-12-31: $148.48M2022-12-31: $101.74M2023-12-31: $83.55M2024-12-31: $70.91M2025-12-31: $69.75M$69.75M2018-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$69.75M-1.6%2026-03-10Balance as of period end2024-12-31$70.91M-15.1%2026-03-10Balance as of period end2023-12-31$83.55M-17.9%2025-02-25Balance as of period end2022-12-31$101.74M-31.5%2024-02-27Balance as of period end2021-12-31$148.48M-35.9%2023-03-01Balance as of period end2020-12-31$231.56M+1468.1%2022-03-01Balance as of period end2019-12-31$14.77M+258.1%2021-03-15Balance as of period end2018-12-31$4.12M—2021-03-15Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)